Release Summary

Navidea announces 4 presentations of Manocept™ data from Kaposi’s Sarcoma studies are scheduled at the International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents, June 30-July 3.

Navidea Biopharmaceuticals, Inc.